The gold standard in PCR diagnostics
Latest news
July 25, 2021
A new study shows that the less-invasive saliva test for COVID-19 gives just as accurate results as those of the nasopharyngeal specimen. A research team at the Department of Laboratory Medicine at Kangwon National University School of Medicine, led by…
July 13, 2021
Seegene launches new multiplex PCR test capable of screening six SARS-CoV-2 variants including the Delta and Delta Plus variants attributable for a recent surge in global COVID-19 cases. The new CE-IVD marked variants detection kit to differentiate 10 major COVID-19…
June 30, 2021
Seegene announces partnership with Bio-Rad for the development and commercialization of infectious disease molecular diagnostic products Diagnostic tests designed for the pandemic and the post-pandemic era with high multiplex technology A significant step forward for Seegene in expanding its business…
Resources
Tomorrow's technology, today
Seegene’s “All in One” platform is a unique, customizable, and optimized automation solution for performing a wide range of molecular diagnostic tests – including multiple target PCR testing – in the areas of infectious diseases, women’s health, and personalized medicine.
Our healthcare partners
“Thanks to Seegene Canada, laboratories like ours have been able to step up and meet the testing demands necessitated by the COVID-19 pandemic.”
 |
Dr. Marc Desjardins, Lead Microbiologist Eastern Ontario Regional Laboratories |
